Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9007
Cytogenetic Studies in Leukemia Patients
Research Committee(s)
Leukemia
Activated
07-15-1991
Closed
01-01-2012
Closed
Phase
Accrual
25%
Published
SWOG Clinical Trial Number
SWOG-9021 (INT-0124) (BTCG-9021) (RTOG-9021)
Postoperative Radiotherapy for Single Brain Metastases, Phase III
Research Committee(s)
Brain Cancer
Activated
07-15-1991
Closed
12-01-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9016
Study of External Brain Irradiation and Cisplatin/BCNU Followed by BCNU For The Treatment of Primary Malignant Brain Tumors
Activated
07-15-1991
Closed
07-01-1992
Closed
Phase
Accrual
3%
SWOG Clinical Trial Number
SWOG-9112
A Phase I Study of the Combination of High Dose Chemotherapy, Granulocytemacrophage Colony Stimulating Factor, and Interleukin-2
Activated
07-15-1991
Closed
11-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9026
A Phase I, Open Label, Multicenter Study of the Safety, Tolerability and Biological Effects of SDZ ILE 964 (Recombinant Human Interleukin-3), Administered to Patients with Metastatic Cancer Prior to and After Receiving a Carboplatin/Etoposide Chemotherapy Regimen
Activated
07-15-1991
Closed
09-29-1992
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
SWOG-8918
Phase II Trial of Piroxantrone in Endometrial Cancer
Activated
07-01-1991
Closed
05-01-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9125
A Phase II Trial of CVAD/Verapamil/Quinine for Treatment of Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
06-01-1991
Closed
02-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9012
Evaluation of Low Dose Alpha-Interferon in Patients with Advanced Renal Cell Carcinoma
Activated
05-01-1991
Closed
05-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8993
Phase II Study of High Dose Melphalan with Hemopoietic Stem Cell Support and GM-CSF in Refractory Multiple Myeloma (MM)
Research Committee(s)
Myeloma
Activated
04-15-1991
Closed
05-01-1996
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9045
Evaluation of Quality of Life in Patients with Advanced Colorectal Cancer Enrolled on SWOG-8905
Activated
03-01-1991
Closed
01-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8949
A Randomized Comparison of Nephrectomy Followed by Interferon Alpha 2-b (Intron-A) vs. Interferon Alpha 2-b (Intron-A) Alone in Patients with Advanced Renal Cell Carcinoma
Research Committee(s)
Genitourinary Cancer
Activated
03-01-1991
Closed
10-01-1998
Closed
Phase
Accrual
67%
Published
SWOG Clinical Trial Number
SWOG-9000
Biomarkers of Colorectal Cancer Prognosis
Research Committee(s)
Gastrointestinal Cancer
Activated
02-15-1991
Closed
09-15-1993
Closed
Phase
Accrual
95%
Published
SWOG Clinical Trial Number
SWOG-9009
Pilot Study for Analysis of Lymphocyte Subsets and Natural Killer Activity after Treatment with Levamisole
Research Committee(s)
Gastrointestinal Cancer
Activated
12-15-1990
Closed
08-07-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9046
Evaluation of 10-EdAM in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II
Activated
12-15-1990
Closed
04-01-1992
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8904
Phase II Trials of Merbarone and Piroxantrone in Ovarian Cancer
Activated
12-01-1990
Closed
02-15-1993
Closed
Phase
Accrual
14%
SWOG Clinical Trial Number
SWOG-8935
Evaluation of Continuous Infusion Interleukin-2 (IL-2) in Patients with Squamous Cell Carcinoma of the Head and Neck, Phase II
Activated
11-15-1990
Closed
06-15-1992
Closed
Phase
Accrual
46%
Published
SWOG Clinical Trial Number
SWOG-8730
Evaluation of Amonafide in Esophageal Cancer
Activated
11-01-1990
Closed
04-15-1992
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8936
Evaluation of Piroxantrone in Gastric Carcinoma
Activated
11-01-1990
Closed
06-15-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9038
Extended Administration of Oral Etoposide and Cyclophosphamide for the Treatment of Advanced Non-Small Cell Lung Cancer
Activated
11-01-1990
Closed
07-01-1991
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-9006
A Phase II 19F Magnetic Resonance Spectroscopy (MRS) Study of 5-FU and Correlation with Clinical Results of 5-FU/Leucovorin (LV) Therapy in Patients with Carcinomas of the Gastrointestinal Tract
Research Committee(s)
Gastrointestinal Cancer
Activated
10-15-1990
Closed
11-01-1996